Iron-Addicted Colorectal Cancers Exploit Heme-Complex II Axis to Resist Oxidative Cell Death

Researchers showed that the canonical anti-ferroptosis response mediated by GPX4 and SLC7A11 is dispensable for colorectal cancer growth and progression in both sporadic and colitis-associated cancer models.